Context Therapeutics Inc (STU:6K9)
€ 0.52 +0.010 (+1.96%) Market Cap: 49.79 Mil Enterprise Value: 2.15 Mil PE Ratio: 0 PB Ratio: 1.06 GF Score: 36/100

Context Therapeutics Inc to Discuss CTIM-76 Phase 1 Interim Results Transcript

Jun 15, 2026 / 12:00 PM GMT


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CNTX.OQ - Context Therapeutics Inc
Context Therapeutics Inc to Discuss CTIM-76 Phase 1 Interim Results
Jun 15, 2026 / 12:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning, everyone, and thank you for standing by. Welcome to the Context Therapeutics CTIMS 76 Phase 1 Interim Clinical Data Call. Please be advised that today's call is being recorded. I would now like to hand the call over to your host for today, Jennifer Manai, Context's Chief Financial Officer. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you. Good morning and thank you for joining us. Before we begin, I would like to remind everyone that during this call, we will be making forward-looking statements. Because forward
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot